Detalhe da pesquisa
1.
Total serum N-glycans associate with response to immune checkpoint inhibition therapy and survival in patients with advanced melanoma.
BMC Cancer
; 23(1): 166, 2023 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36805683
2.
Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma.
Nat Med
; 30(3): 785-796, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38365950
3.
Tebentafusp: a first-in-class treatment for metastatic uveal melanoma.
Ther Adv Med Oncol
; 15: 17588359231160140, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36970111
4.
Circulating inflammatory proteins associate with response to immune checkpoint inhibition therapy in patients with advanced melanoma.
EBioMedicine
; 83: 104235, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36007304
5.
Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma.
Nat Med
; 28(3): 535-544, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35228751
6.
Role of the gut microbiome for cancer patients receiving immunotherapy: Dietary and treatment implications.
Eur J Cancer
; 138: 149-155, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32889369
7.
Mycophenolate mofetil alongside high-dose corticosteroids: optimizing the management of combination immune checkpoint inhibitor-induced colitis.
Melanoma Res
; 29(1): 102-106, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30395075
8.
Phase I dose escalation study of the anti insulin-like growth factor-I receptor monoclonal antibody CP-751,871 in patients with refractory solid tumors.
Clin Cancer Res
; 13(19): 5834-40, 2007 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17908976
9.
Emerging treatment options for recurrent ovarian cancer: the potential role of olaparib.
Onco Targets Ther
; 6: 1197-206, 2013 Sep 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-24043945
10.
Vemurafenib in melanoma.
Expert Rev Anticancer Ther
; 13(5): 513-22, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23617343
11.
Oncogenic B-RAF(V600E) signaling induces the T-Box3 transcriptional repressor to repress E-cadherin and enhance melanoma cell invasion.
J Invest Dermatol
; 133(5): 1269-77, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23190890
12.
The retinoblastoma protein modulates Tbx2 functional specificity.
Mol Biol Cell
; 21(15): 2770-9, 2010 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20534814
13.
A first-in-man phase i and pharmacokinetic study on CHR-2797 (Tosedostat), an inhibitor of M1 aminopeptidases, in patients with advanced solid tumors.
Clin Cancer Res
; 15(15): 4978-85, 2009 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19638462